Solvay SA (“Solvay” or the “Company”) announced today that it intends to exercise its issuer make-whole call option under the terms of the indenture governing the 4.450% Senior Notes due 2025 issued ...

Today marks a new era for Solvay and its stakeholders as it looks to a future as a simpler, more focused company post the Syensqo spin-off (subject to the approval by Solvay’s shareholders at the ...

2029 Bonds to be Redeemed, Trade under Review, No Bondholder Meeting Brussels, 4 September 2023 at 9.00pm CEST – As part of the consent solicitation announced on 4 August 2023 in relation to Solvay SA ...

In line with Belgian transparency legislation (Law of May 2, 2007), BNP Paribas Asset Management Holding recently sent to Solvay the following transparency notification indicating that they crossed ...

Belgian drugs, chemicals and plastics maker Solvay said on Monday it would sell its drugs unit to U.S. partner Abbott Laboratories for 4.5 billion euros ($6.6 billion) in cash and reinvest in ...

Consents on 2025 and 2027 Bonds Successful Tender on 2024 Hybrid Bonds Successful 2029 Bonds to be Redeemed, Trade under Review, No Bondholder Meeting Solvay intends to exercise its issuer make-whole ...